NCT04379960View on ClinicalTrials.gov

Identification of Immunogenic Neo-epitopes for the Development of Personalised Pancreatic Cancer Vaccines

CompletedOBSERVATIONAL
Enrollment

192

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

October 31, 2021

Study Completion Date

October 31, 2021

Conditions
The Initial Aim of This Project is to Perform in Vitro Validation of Neoepitope Candidates Selected From Available Mutanome Data
Interventions
OTHER

Peptides

Peptides will be added to PBMCs in in vitro cell culture.

Trial Locations (1)

EC1M 6BQ

Barts Cancer Institute, London

All Listed Sponsors
lead

Queen Mary University of London

OTHER

NCT04379960 - Identification of Immunogenic Neo-epitopes for the Development of Personalised Pancreatic Cancer Vaccines | Biotech Hunter | Biotech Hunter